Natera Inc (NTRA)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account

Sell

$231.70

Buy

$235.00

arrow-up$4.97 (+2.19%)

Prices updated at 19 Jun 2026, 00:59 EDT

Prices minimum 15 mins delay

Prices in USD

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus ...

NASDAQ

1.91%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$237.15 - $227.93
	$256.36 - $131.81
	-
	33,141.47m
	-
	-
	2,630,815
	18.68
	1,343,201.03
	1.98
	139.69m
	US6323071042
	-1.62
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.